產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CILP抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CILP抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CILP
Cat. Number:
Anti-CILP抗體KL-13954R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Major alterations in the compositionAnti-CILP抗體 of the cartilage extracellular matrix occur in joint disease, such as osteoarthrosis. This gene encodes the cartilage intermediate layer protein (CILP), which increases in early osteoarthrosis cartilage. The encoded protein was thought to encode a protein precursor for two different proteins; an N-terminal CILP and a C-terminal homolog of NTPPHase, however, later studies identified no nucleotide pyrophosphatase phosphodiesterase (NPP) activity. The full-length and the N-terminal domain of this protein was shown to function as an IGF-1 antagonist. An allelic variant of this gene has been associated with lumbar disc disease. [provided by RefSeq, Sep 2010]
Also known as:
Cartilage intermediate layer protein 1 C1;Anti-CILP抗體 Cartilage intermediate layer protein 1 C2; cartilage intermediate layer protein; cartilage intermediate layer protein, nucleotide pyrophosphohydrolase; Cartilage intermediate-layer protein; CILP 1; CILP; CILP-1; CILP1_HUMAN; HGNC:1980; HsT18872.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow,Anti-CILP抗體 Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CILP.
●
Predicted Molecular Weight: 132kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-CILP抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl081Ra01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Si01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl083Hu01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Mu01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Po01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Ra01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl085Bo01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Ca01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Cp01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Hu01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Mu01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Po01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Ra01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl086Bo01 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
kl086Hu01 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
kl086Mu01 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
